Healthlead Public Company Limited (BKK: HL)

Market Cap	2.22B
Revenue (ttm)	1.83B
Net Income (ttm)	76.21M
Shares Out	272.00M
EPS (ttm)	0.28
PE Ratio	29.09
Forward PE	n/a
Dividend	0.15 (1.84%)
Ex-Dividend Date	Mar 13, 2024

Volume	289,514
Open	8.30
Previous Close	8.15
Day's Range	8.15 - 8.35
52-Week Range	7.10 - 12.80
Beta	0.17
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 13, 2024

About Healthlead Public Company

Healthlead Public Company Limited, together with its subsidiaries, engages in development, import, and distribution of drugs, pharmaceuticals, cosmetic products, dietary supplements, medical equipment, other health products. It offers medicines, medical supplies, and medical devices, as well as disinfectant and deodorizing products comprising mask products under the iCare, Pharmax, vitaminclub, and Super Drug brands; and dietary supplements under the PRIME and Besuto brand names. Healthlead Public Company Limited was incorporated in 2018 and is...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 2018
• Country: Thailand
• Stock Exchange: Stock Exchange of Thailand
• Ticker Symbol: HL

Financial Performance

In 2023, HL's revenue was 1.66 billion, an increase of 7.87% compared to the previous year's 1.54 billion. Earnings were 74.68 million, a decrease of -36.84%.